MedPath
FDA Approval

Ezetimibe and Simvastatin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 6, 2023
Labeling Type
Human Prescription Drug Label
Ezetimibe(10 mg in 1 1)
Simvastatin(40 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

A-S Medication Solutions

A-S Medication Solutions

830016429

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ezetimibe and Simvastatin

Product Details

NDC Product Code
50090-4772
Application Number
ANDA209222
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
November 30, 2021
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
ISOPROPYL ALCOHOLInactive
Code: ND2M416302Class: IACT
PROPYL GALLATEInactive
Code: 8D4SNN7V92Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2UClass: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
EzetimibeActive
Code: EOR26LQQ24Class: ACTIBQuantity: 10 mg in 1 1
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
Code: AGG2FN16EVClass: ACTIBQuantity: 40 mg in 1 1
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
© Copyright 2025. All Rights Reserved by MedPath